|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 108 studies with search of: | "Gastrointestinal Stromal Tumors" |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Gastrointestinal Stromal Tumors (GIST) Registry
|
||||
| 2 | Active, not recruiting |
Open-Label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors
|
||||
| 3 | Completed |
Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting
|
||||
| 4 | Completed |
Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)
|
||||
| 5 | Recruiting |
Efficacy and Safety of Masitinib (AB1010) in Comparison to Imatinib in Patients With Gastro-intestinal Stromal Tumour
|
||||
| 6 | Active, not recruiting |
Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors
|
||||
| 7 | Completed |
Temozolomide in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors
|
||||
| 8 | Recruiting |
Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
|
||||
| 9 | Completed |
Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery
|
||||
| 10 | Active, not recruiting |
Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001
|
||||
| 11 |
Completed Has Results |
Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of Coquimbo
|
||||
| 12 | Active, not recruiting |
Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)
|
||||
| 13 | Recruiting |
Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib
|
||||
| 14 | Active, not recruiting |
Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors
|
||||
| 15 | Active, not recruiting |
Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
|
||||
| 16 | Recruiting |
Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg
|
||||
| 17 | Active, not recruiting |
Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib
|
||||
| 18 | Active, not recruiting |
Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)
|
||||
| 19 | Recruiting |
Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor
|
||||
| 20 | Recruiting |
Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|